Background: Point-of-care testing for C-reactive protein (CRP) may be helpful in differentiating viral from bacterial infection. Such a device should give results comparable to laboratory testing. The aim was to evaluate two point-of-care CRP tests (Nycocard and QuikRead) in febrile children in general practice, compared to a reference immunoturbidimetric assay. Methods: A cross-sectional study was carried out of febrile children aged 3 months to 6 years presented to a general practice out-of-hours service. Children were visited at home where blood was taken for tests, within 24 h after presentation. The Nycocard test was performed at home, whereas the QuikRead and reference test were performed in the laboratory. Results: A total of 76 children were enrolled. All three CRP tests were performed in 59 children. The mean difference between the reference test and Nycocard and QuikRead was 0.6 and y6.1 mg/L, respectively. The slope of the Passing-Bablok regression was 0.95 (95% CI 0.9-1.0) and 0.83 (95% CI 0.81-0.85) for the Nycocard and QuikRead tests, respectively. Conclusions: Up to a concentration of 160 mg/L, the Nycocard test correlated well with the reference test, while the QuikRead test underestimated concentrations above 60 mg/L. The Nycocard test seems a good candidate for CRP point-of-care testing in general practice.
Introduction
Fever is very common among children in general practice (1) . Febrile children are often presented in the evening, outside normal office hours and are there- fore mostly seen in general practice out-of-hours services. Fever generally has no serious consequences, but approximately 1% of children develop a serious bacterial infection (SBI), e.g., pneumonia or meningitis, with possible life-threatening complications (2, 3) . Early recognition and treatment of SBI leads to a better prognosis (4, 5) . Differentiating the few bacterial infections from the bulk of self-limiting viral infections in febrile children is a great challenge for general practitioners.
The use of near-patient or point-of-care testing (POCT) for C-reactive protein (CRP) measurement in general practice has the advantage of providing a result within minutes, making early diagnosis and management of bacterial infections possible. Such POCT devices should give results comparable to reference testing and be feasible to use in daily practice.
CRP is the first described acute-phase protein, produced by hepatocytes as part of the non-specific acute-phase response to infection, inflammation and tissue damage (6) . CRP values in healthy individuals are below 10 mg/L. After the onset of inflammation or tissue injury, CRP concentrations rapidly increase in the first 6 h, reach maximal levels after approximately 48 h, and fall rapidly when stimulation ends. Therefore, CRP serves as a very useful marker in screening for infectious and inflammatory diseases, as well as for monitoring the response to treatment or disease activity (6, 7) .
The aim of this study was to evaluate two different POCT devices for CRP measurement, the Nycocard CRP and the QuikRead CRP, in febrile children presented to a general practice out-of-hours service.
Materials and methods

Patients
Febrile children, aged 3 months to 6 years, presented at a general practice out-of-hours service in Rotterdam on Monday to Thursday evenings were eligible for the study. Children were enrolled between March 7 and May 31, 2005.
The receptionist of the service questioned the parents about the child's fever. The parents were informed about the study and were visited at home by a research assistant within 24 h. During the home visit, the parents answered a structured questionnaire and the child was physically examined following a structured scheme. A finger prick in the middle finger was performed according to the NCCLS protocol (8) . The capillary blood obtained was immediately used to perform the Nycocard CRP test. Another 400 mL of blood was drawn into a heparin microtainer. Subsequently, the tubes were centrifuged and plasma was stored at y208C until measurement.
Parents gave written informed consent. Children resisting physical examination or the finger prick were not enrolled. 
Primary outcome measure
The primary outcome measure was the difference between the CRP value measured by the reference test and the POCT CRP tests, in mg/L.
CRP tests
For the Nycocard CRP test (Clindia Diagnostics, Leusden, The Netherlands), 5 mL of whole blood was taken to determine the CRP value (in mg/L) using the Nycocard test kit. Two medical students performed all measurements. The medical students were trained by highly qualified laboratory technicians of the Department of Clinical Chemistry during five sessions before performing the Nycocard CRP test in children.
The QuikRead CRP test (Orion Corporation, Orion Diagnostica, Espoo, Finland) has been evaluated on the QuikRead System for both whole blood (20 mL) and plasma. In our evaluation protocol, this CRP test was performed on plasma by trained laboratory technicians who were blinded to the results of the reference test, the Nycocard test and patient characteristics. Aliquots of 20 mL of plasma were used to determine the CRP value (in mg/L).
For the reference CRP test, the Tina-quant CRP Hitachi 912 (Roche Diagnostics, Penzberg, Germany) was used, which has been standardized against CRM 470 (9) . All plasma samples were analyzed in one batch after the enrollment period and laboratory technicians were blinded to the POCT CRP results.
Patient characteristics
Since the medical students were not blinded to the patient characteristics, the Nycocard CRP results may be influenced by characteristics of the children such as gender, fever height, fever duration at the time of CRP measurement, and an ''illness score''. This latter score is a measure of the first impression of the general condition or illness of the child. It is categorized into not ill, slightly ill, moderately ill and seriously ill. These characteristics were assessed during the home visit.
Statistical analysis
The linear association between the results given by the POCT CRP tests and the reference test was analyzed using Pearson's correlation coefficient. The agreement between the results was analyzed with the intraclass correlation coefficient (ICC). The ICC produces measures of agreement of values within cases and ranges from 0 to 1. An ICC of 0.8 is accepted as good agreement (10) .
The differences between the POCT CRP tests and the reference test were analyzed using the Bland and Altman method (11) and Passing and Bablok regression (12) . We considered the POCT CRP test clinically valid when results did not deviate by more than 10 mg/L from the results of the reference test in the concentration range 0-70 mg/L.
The non-parametric Mann-Whitney test was used to test the relationship between the patient characteristics gender, body temperature, fever duration and illness score, and the difference between the Nycocard test and the reference test. Body temperature was dichotomized at 388C, fever duration at 24 h, and illness score at not ill vs. ill (slightly, moderately and seriously ill).
Assuming an ICC of 0.9, a minimum of 46 individuals had to be included to reject the null hypothesis of ICCs0.8 with as0.05 and a power of 80%.
Results
During the enrollment period, 76 children were visited. In 15 children, CRP values could not be measured by the reference test due to insufficient material. The main reasons for insufficient material were no consent for the finger prick and resistance of the child. Nycocard CRP and QuikRead CRP measurement results were available for 61 and 59 children, respectively. Rectal temperature could not be measured in two children and the axillary temperature was measured in another child.
The characteristics of the 76 children enrolled are presented in Table 1 . The median age was 21 months (ranging from 3 to 71 months). The 61 children with full CRP data tended to be older, more often male and to have a longer duration of fever. The median height of the fever in these 61 children was 37.78C (ranging from 34.8 to 39.98C) and did not differ from the children lacking reference CRP data.
Agreement
The correlation coefficients for both CRP tests with the reference test were 0.99. The overall ICC value and the ICC value in the concentration range 0-70 mg/L were 0.99 for the Nycocard and 0.98 for the QuikRead test.
Bland-Altman analysis
The overall mean difference between the Nycocard CRP test and the reference test was 0.6 mg/L (ns61; 2 SD 19.7). In the concentration range of 0-70 mg/L the mean difference was 1.4 mg/L (ns46; 2 SD 11) and for concentrations above 70 mg/L the mean difference was y1.9 mg/L (ns15; 2 SD 35.4). The overall mean difference between the QuikRead test and the reference test was y6.1 mg/L (ns59; 2 SD 31.3). In the concentration range 0-70 mg/L the mean difference was y0.4 mg/L (ns46; 2 SD 11.8) and for concentrations above 70 mg/L the mean difference was y26.4 mg/L (ns13; 2 SD 44). Bland-Altman plots are presented in Figure 1 .
Of the Nycocard results, 89% fell within "10 mg/L of the reference test results. In the concentration range 0-70 mg/L, the maximum difference was exceeded in 2 out of 46 results (4.3%), by 14 and 24 mg/L. Of the QuikRead results, 78% fell within "10 mg/L of the reference test results. In the concentration range 0-70 mg/L, the maximum difference was exceeded in 2 out of 46 results (4.3%), by y15 and y28 mg/L.
Passing-Bablok analysis
The intercept of the Nycocard and reference test comparison was 2.3 (95% CI 1.0-3.4) with a slope of 0.95 (95% CI 0.9-1.0). The cusum test p-value was between 0.01 and 0.05. In the QuikRead and reference test comparison, the intercept was 3.9 (95% CI 3.3-4. 
Patient characteristics
None of the patient characteristics (gender, duration and height of fever, and illness score) was related to differences between the reference test and the Nycocard test (p-values 0.23-0.73). The distribution of CRP values for each of the three tests in the illness score categories (ill represents six moderately ill and one seriously ill) is presented in Figure 3 .
Discussion
In this study two CRP POCT devices for clinical use in febrile children in general practice were compared to a routinely used laboratory method. (16); therefore, the POCT device needs to correlate well in this concentration range. In the clinically relevant range, the maximum difference was exceeded in only 4.3% of cases for both tests.
The Nycocard test produced higher values than the reference test, overall as well as in the case of outliers in the concentration range 0-70 mg/L. The QuikRead test, however, produced increasingly lower values than the reference test above 40 mg/L, which is in the clinically relevant range. Possible consequences of this imprecision in daily practice may be unnecessary prescription of antibiotics and more hospital referrals using the Nycocard test, or missing children with bacterial infection using the QuikRead test. Randomized controlled trials are needed to evaluate the possible consequences.
Medical students performed the Nycocard test during home visits in general practice, whereas experienced personnel in the laboratory performed the QuikRead test. This could explain the larger distribution with the Nycocard test in the range 0-70 mg/L and might indicate that the QuikRead would perform less well in daily practice. However, overall the QuikRead test would be expected to perform better in the laboratory by trained technicians compared to the Nycocard test performed at home.
The Nycocard CRP test can be carried out within 5 min using only 5 mL of whole blood, whereas the QuikRead test requires dilution of 20 mL of whole blood with 1 mL of buffer, after which a blank measurement is needed. Although we did not evaluate the use of the QuikRead System at home, the use of the Nycocard test at home seems to be more feasible because fewer actions are needed. The patient characteristics height and duration of fever, gender and illness score were not related to the difference between the Nycocard and the reference CRP values. Thus, when CRP measurement is performed on a POCT device by a general practitioner or assistant, these variables do not seem to influence the results.
Our results are in accordance with the results of other studies using the Nycocard device. Most studies concluded that use of the Nycocard was acceptable for POCT (17) (18) (19) . Our results for the QuikRead test are different from previous studies. We are aware of two studies evaluating the QuikRead test, one in general practice (20) and one in an emergency room setting (21) . Seamark et al. tested the device in patients referred with a variety of conditions and found a mean difference of 1 mg/L, with 95% of the POCT results within "10 mg/L of the mean value; the age of the patients was not reported (20) . Esposito et al. concluded that the QuikRead and the standard reference assay showed similar median CRP levels and a similar distribution of values (21) . Both studies concluded that the QuikRead test showed reliable performance compared to a reference method. Taking into account the increasing underestimation of CRP values above 60 mg/L and the more labor-intensive method, we feel that, although not tested in daily practice, the QuikRead test is less suitable for CRP testing in general practice or an emergency room setting and is more suitable for a laboratory setting.
The use of CRP as a diagnostic marker for SBI has been extensively studied and debated. Several studies indicate that an increased CRP concentration is related to a higher risk of SBI in febrile children (14) (15) (16) 22) . However, the management of febrile children by the general practitioner should be based not only on a CRP value, but also on other grounds such as clinical presentation, duration of symptoms and medical history. Our results show that the elevation of CRP concentration tends to be higher and the distribution of CRP values to be more widespread among febrile children who appear ill compared to children who appear well. To determine the effect of CRP POCT on clinical decision-making, further large prospective studies are needed (23) . In addition, highquality diagnostic studies are needed to clarify the added diagnostic value of CRP along with other variables in differentiating bacterial from viral infections.
The use of POC CRP tests in general practice for the early diagnosis and management of febrile children is promising. We feel that the Nycocard CRP test is a good candidate for this purpose.
